Dibekacin

TargetMol
Product Code: TAR-T23993
Supplier: TargetMol
CodeSizePrice
TAR-T23993-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Dibekacin is an antibiotic.
CAS:
34493-98-6
Formula:
C18H37N5O8
Molecular Weight:
451.521
Purity:
0.98
SMILES:
NC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)O1

References

1. Umemura E, Sakamoto Y, Takahashi Y, Miyake T. Synthesis and antibacterial activity of 1-N-[(S)-?-amino-2-hydroxyalkyl] derivatives of dibekacin, 5-deoxydibekacin, 3'-deoxykanamycin A and gentamicin B. J Antibiot (Tokyo). 2015 Jun;68(6):421-3. doi: 10.1038/ja.2015.6. Epub 2015 Feb 25. PubMed PMID: 25712399. 2. Lopitaux R, Hermet R, Sirot J, Cluzel M. [Dibekacin in the treatment of urinary infections in the elderly]. Pathol Biol (Paris). 1984 Jun;32(5 Pt 2):563-6. French. PubMed PMID: 6462747. 3. Kitasato I, Niizato T, Watanabe T, Inouye S. Reduction of dibekacin-induced nephrotoxicity in the rat by the formation of N-alkylsulfonate derivatives. Drugs Exp Clin Res. 1989;15(6-7):239-47. PubMed PMID: 2591296. 4. Sasaki K, Kobayashi Y, Kurihara T, Yamashita Y, Takahashi Y, Miyake T, Akamatsu Y. Synthesis and antibacterial activity of 4? or 6?-alkanoylamino derivatives of arbekacin. J Antibiot (Tokyo). 2015 Dec;68(12):741-7. doi: 10.1038/ja.2015.61. Epub 2015 May 20. PubMed PMID: 25990952.